Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wysokinski, Andrzej
ELEVATE 2, NCT04712669 / 2020-004971-42: A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension	Completed	2	108	Europe, Canada, US, RoW	rodatristat ethyl 300 mg tablet BID, rodatristat ethyl 600 mg BID, Placebo	Altavant Sciences GmbH	Pulmonary Arterial Hypertension	06/23	08/23
NCT04433052: Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD	Recruiting	N/A	12000	Europe	personalised prevention program (PPP)	Tampere University	Coronary Heart Disease	12/26	12/26